Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK’s RSV vaccine ready to launch

March 9, 2023
Sales and Marketing

GSK has announced that it is ready to launch its respiratory syncytial virus (RSV) vaccine in the US at some …

News

Eli Lilly & Co’s Alzheimer’s disease drug fails to stop disease decline

March 9, 2023
Research and Development

Eli Lilly & Co have today announced that its Alzheimer’s disease (AD) hopeful did not slow the progression of cognitive …

News

AstraZeneca shares positive results from Imfinzi trial

March 9, 2023
Research and Development

Pharma giant AstraZeneca has shared positive results from a phase 3 trial on Imfinzi, its resectable non-small cell lung cancer …

News

Respiree gets FDA clearance for cardio-respiratory wearable

March 9, 2023
Medical Communications

Respiree, a digital therapeutics start-up, has secured the 510(k) FDA clearance for its RS001 cardio-respiratory wearable.   RS001 is a …

News

New clinical trial aims to find new endometriosis treatment

March 8, 2023
Research and Development

A new clinical trial is set to begin shortly which will be a collaboration between the universities of Edinburgh, Aberdeen …

News

Abbott’s concussion-detecting blood test approved by FDA

March 8, 2023
Medical Communications

US-based Abbott, a medical technology company, has received FDA approval for its laboratory blood test which detects traumatic brain injury …

News

Hospital for Special Surgery reveals 3D surface topographic scan for scoliosis patients

March 8, 2023
Medical Communications

Researchers at New York City’s Hospital for Special Surgery (HSS) have found that using a 30-camera array, or 3dMD, can …

News

FDA grants de novo approval to Neuromod’s tinnitus device

March 8, 2023
Medical Communications

The FDA has granted de novo approval to Neuromod’s Lenire device which includes Bluetooth headphones, a handheld controller and the …

News

Redx Announces RXC004 Topline Data From a Phase 2 Monotherapy Module

March 8, 2023
Business Services

Alderley Park, UK, 8 March 2023 Redx (AIM:REDX), the clinical-stage biotechnology company focused on discovering and developing novel, small molecule, …

News
Press release

POLB 001 patent portfolio strengthened through granting of US patent

March 8, 2023
Business Services

8 March 2023 – Poolbeg Pharma (AIM: POLB, OTCQB: POLBF, ‘Poolbeg’ or the ‘Company’),  a leading infectious disease focused biopharmaceutical …

News
Press release

Chiesi Group and Affibody collaborate to develop and commercialize innovative treatments for respiratory diseases

March 7, 2023
Business Services

Parma, Italy and Solna, Sweden, March 7th, 2023 – Chiesi Farmaceutici S.p.A (“Chiesi Group”) and Affibody AB (“Affibody”) today announced …

News
Press release

Funding to increase access to early phase clinical trials given to Yale Cancer Center

March 7, 2023
Sales and Marketing

Yale Cancer Center has announced it has received collaborative funding aiming to support and increase access to early phase clinical …

News

Wearable sensor helps detect heart attacks

March 7, 2023
Research and Development

RCE Technologies has developed a bracelet-like device that can measure levels of troponin-I in the patient’s blood, providing a more …

News

BioMarin receives FDA update for gene therapy for adults with severe haemophilia A

March 7, 2023
Medical Communications

Global biotechnology company BioMarin Pharmaceutical has announced that it’s received an update from the FDA, detailing the extension of their …

News

Sooma receives FDA Breakthrough Device designation for depression therapy device

March 7, 2023
Medical Communications

Finnish company Sooma Medical has received Breakthrough Device designation by the FDA for its portable, at-home neuromodulation device to treat …

News

Late-Breaking Phase 3 A DUE Data Show Investigational Single-Tablet Combination Therapy of Macitentan and Tadalafil Significantly Improves Pulmonary Haemodynamics versus Monotherapy in Patients with Pulmonary Arterial Hypertension (PAH)

March 6, 2023
Business Services

BEERSE, Belgium, 6 March, 2023 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced results from the Phase …

News
Press release

Moderna chooses Oxfordshire for new UK facility

March 6, 2023
Manufacturing and Production

US biotech firm Moderna has chosen Harwell Science Campus in Oxfordshire for its new UK R&D facility. The campus is …

News

Bristol Myers Squibb and Viz.ai sign multi-year partnership for HCM device

March 6, 2023
Medical Communications

Bristol Myers Squibb and Viz.ai, an AI-powered medical imaging company, have signed a deal to use AI to detect and …

News

Abbott announces positive clinical study data for both TriClip system and MitraClip therapy

March 6, 2023
Research and Development

Abbott has announced positive data from two separate studies, which looked at its TriClip transcatheter edge-to-edge repair (TEER) system and …

News

Lilly receives approval for expanded indication for breast cancer therapy

March 6, 2023
Research and Development

Following positive data from Eli Lilly’s phase 3 monarchE trial, the FDA has granted approval for the expanded indication for …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025